Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 789 |
|
|||||
| News | - | ||||||
| Day High | 5.10 | Low High |
|||||
| Day Low | 5.09 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Champions Oncology Inc | CSBR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.035 | 0.69% | 5.10 | 11:09:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.09 | 5.09 | 5.10 | 5.065 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15 | 789 | $ 5.10 | $ 4,024 | - | 4.17 - 7.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:35:57 | 3 | $ 5.28 | USD |
Champions Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 13.59M | - | 53.87M | -5.34M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Champions Oncology News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CSBR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.99 | 5.30 | 4.8801 | 5.02 | 3,870 | 0.11 | 2.20% |
| 1 Month | 5.30 | 5.40 | 4.765 | 5.05 | 2,980 | -0.20 | -3.77% |
| 3 Months | 6.04 | 6.26 | 4.765 | 5.58 | 4,287 | -0.94 | -15.56% |
| 6 Months | 6.39 | 7.17 | 4.5101 | 5.61 | 8,626 | -1.29 | -20.19% |
| 1 Year | 5.25 | 7.32 | 4.17 | 5.74 | 8,646 | -0.15 | -2.86% |
| 3 Years | 11.25 | 11.53 | 3.75 | 7.77 | 14,158 | -6.15 | -54.67% |
| 5 Years | 7.78 | 14.68 | 3.75 | 8.28 | 22,856 | -2.68 | -34.45% |
Champions Oncology Description
| Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. |
